Debra Compton

9.9k total citations · 4 hit papers
13 papers, 8.0k citations indexed

About

Debra Compton is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Debra Compton has authored 13 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 3 papers in Oncology. Recurrent topics in Debra Compton's work include Angiogenesis and VEGF in Cancer (3 papers), Neuropeptides and Animal Physiology (3 papers) and Muscle Physiology and Disorders (2 papers). Debra Compton is often cited by papers focused on Angiogenesis and VEGF in Cancer (3 papers), Neuropeptides and Animal Physiology (3 papers) and Muscle Physiology and Disorders (2 papers). Debra Compton collaborates with scholars based in United States. Debra Compton's co-authors include George D. Yancopoulos, Peter C. Maisonpierre, Stanley J. Wiegand, Samuel Davis, Czeslaw Radziejewski, Thomas H. Aldrich, Pamela F. Jones, Chitra Suri, Jocelyn Holash and David Zagzag and has published in prestigious journals such as Science, Cell and Nucleic Acids Research.

In The Last Decade

Debra Compton

13 papers receiving 7.8k citations

Hit Papers

Angiopoietin-2, a Natural Antagonist for Tie2 That Disrup... 1996 2026 2006 2016 1997 1999 1996 1996 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
    1997 2.8k citations Peter C. Maisonpierre, Chitra Suri et al. Science profile →
  2. Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
    1999 1.7k citations Jocelyn Holash, Peter C. Maisonpierre et al. Science profile →
  3. Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning
    1996 1.6k citations Samuel Davis, Thomas H. Aldrich et al. Cell profile →
  4. The Receptor Tyrosine Kinase MuSK Is Required for Neuromuscular Junction Formation In Vivo
    1996 749 citations Thomas M. DeChiara, David C. Bowen et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Debra Compton United States 12 5.8k 1.9k 1.3k 1.3k 1.2k 13 8.0k
Chitra Suri United States 15 6.4k 1.1× 1.9k 1.0× 1.7k 1.3× 1.3k 1.1× 1.6k 1.4× 19 9.2k
Joyce McClain United States 15 5.2k 0.9× 1.5k 0.8× 1.5k 1.2× 2.0k 1.6× 1.3k 1.1× 17 8.3k
Czeslaw Radziejewski United States 26 6.6k 1.1× 1.7k 0.9× 1.9k 1.5× 2.0k 1.6× 1.1k 0.9× 39 10.5k
John S. Rudge United States 38 6.4k 1.1× 1.9k 1.0× 1.8k 1.4× 1.7k 1.3× 879 0.7× 57 10.9k
Thomas H. Aldrich United States 15 5.7k 1.0× 1.5k 0.8× 1.6k 1.3× 2.1k 1.7× 1.2k 1.0× 17 8.7k
Joe Kowalski United States 23 5.8k 1.0× 2.0k 1.0× 1.8k 1.4× 777 0.6× 461 0.4× 25 8.7k
Ahuva Itin Israel 33 7.9k 1.4× 3.5k 1.8× 1.7k 1.3× 634 0.5× 576 0.5× 52 12.9k
Karen Carver-Moore United States 15 3.9k 0.7× 1.2k 0.6× 1.7k 1.3× 743 0.6× 474 0.4× 16 7.9k
Injune Kim South Korea 40 4.4k 0.8× 1.5k 0.8× 1.0k 0.8× 370 0.3× 1.3k 1.1× 63 7.1k
Yasufumi Sato Japan 55 7.3k 1.3× 2.4k 1.3× 1.8k 1.4× 945 0.8× 371 0.3× 261 11.1k

Countries citing papers authored by Debra Compton

Since Specialization
Citations

This map shows the geographic impact of Debra Compton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra Compton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra Compton more than expected).

Fields of papers citing papers by Debra Compton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debra Compton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra Compton. The network helps show where Debra Compton may publish in the future.

Co-authorship network of co-authors of Debra Compton

This figure shows the co-authorship network connecting the top 25 collaborators of Debra Compton. A scholar is included among the top collaborators of Debra Compton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debra Compton. Debra Compton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Holash, Jocelyn, Peter C. Maisonpierre, Debra Compton, et al.. (1999). Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF. Science. 284(5422). 1994–1998. 1749 indexed citations breakdown →
3.
Maisonpierre, Peter C., Chitra Suri, Pamela F. Jones, et al.. (1997). Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis. Science. 277(5322). 55–60. 2842 indexed citations breakdown →
4.
Thiagalingam, Arunthathi, A de Bustros, Michael Borges, et al.. (1996). RREB-1, a Novel Zinc Finger Protein, Is Involved in the Differentiation Response to Ras in Human Medullary Thyroid Carcinomas. Molecular and Cellular Biology. 16(10). 5335–5345. 123 indexed citations
5.
Davis, Samuel, Thomas H. Aldrich, Pamela F. Jones, et al.. (1996). Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning. Cell. 87(7). 1161–1169. 1595 indexed citations breakdown →
6.
DeChiara, Thomas M., David C. Bowen, David M. Valenzuela, et al.. (1996). The Receptor Tyrosine Kinase MuSK Is Required for Neuromuscular Junction Formation In Vivo. Cell. 85(4). 501–512. 749 indexed citations breakdown →
7.
Curtis, Rory, Jennifer Stark, Debra Compton, et al.. (1995). Differential role of the low affinity neurotrophin receptor (p75) in retrograde axonal transport of the neurotrophins. Neuron. 14(6). 1201–1211. 183 indexed citations
8.
Valenzuela, David M., Trevor N. Stitt, Peter S. DiStefano, et al.. (1995). Receptor tyrosine kinase specific for the skeletal muscle lineage: Expression in embryonic muscle, at the neuromuscular junction, and after injury. Neuron. 15(3). 573–584. 345 indexed citations
9.
Cheng, Linzhao, David P. Gearing, Lynn S. White, et al.. (1994). Role of leukemia inhibitory factor and its receptor in mouse primordial germ cell growth. Development. 120(11). 3145–3153. 94 indexed citations
10.
Bustros, A de, et al.. (1992). Regulation of human calcitonin gene transcription by cyclic AMP. Biochemical and Biophysical Research Communications. 189(2). 1157–1164. 27 indexed citations
11.
Ball, Douglas W., Debra Compton, Barry D. Nelkin, Stephen B. Baylin, & A de Bustros. (1992). Human Calcitonin gene regulation by helix-loop-nelix recognition sequences. Nucleic Acids Research. 20(1). 117–123. 30 indexed citations
12.
Bustros, A de, et al.. (1990). Differential utilization of calcitonin gene regulatory DNA sequences in cultured lines of medullary thyroid carcinoma and small-cell lung carcinoma.. Molecular and Cellular Biology. 10(4). 1773–1778. 22 indexed citations
13.
Bustros, A de, et al.. (1990). Differential Utilization of Calcitonin Gene Regulatory DNA Sequences in Cultured Lines of Medullary Thyroid Carcinoma and Small-Cell Lung Carcinoma. Molecular and Cellular Biology. 10(4). 1773–1778. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chitra Suri Breakdown of academic impact, for papers by Joyce McClain Breakdown of academic impact, for papers by Czeslaw Radziejewski Breakdown of academic impact, for papers by John S. Rudge Breakdown of academic impact, for papers by Thomas H. Aldrich Breakdown of academic impact, for papers by Joe Kowalski Breakdown of academic impact, for papers by Ahuva Itin Breakdown of academic impact, for papers by Karen Carver-Moore Breakdown of academic impact, for papers by Injune Kim Breakdown of academic impact, for papers by Yasufumi Sato
Rankless by CCL
2026